Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Sandoz spin-off Nabriva gets €42mm with Series A round; adds €15mm

Executive Summary

Nabriva GMBH has spun out from Sandoz and raised €42mm ($50.1mm) through a Series A financing led by Nomura. Other participants in the round included Global Life Science Ventures, HBM, Novartis BioVentures, and Wellcome Trust.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Spin-Off
    • Venture Financing

Related Companies